Watch multidisciplinary experts discuss key challenges in treating patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). They evaluate the unmet treatment needs, the evidence for using nonsteroidal mineralocorticoid receptor antagonists (MRAs) and how these agents may be incorporated into daily clinical practice.

🔸View the full activity here: [ Ссылка ]

This activity is funded by an independent medical education grant from Bayer AG. This activity is jointly provided by USF Health and touchIME.

🔸Don't forget to follow touchENDOCRINOLOGY on our other social platforms so you never miss a thing:
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
Linkedin: [ Ссылка ]
Website: [ Ссылка ]

#CardiovascularRisk #ChronicKidneyDisease #Diabetes #T2D #CKD
#mineralocorticoidreceptors #MRAs

свернуть